Zyban Related Published Studies
Well-designed clinical trials related to Zyban (Bupropion)
Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy
subjects. [2015]
Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized,
double-blind study. [2014]
SSRI versus bupropion effects on symptom clusters in suicidal depression: post
hoc analysis of a randomized clinical trial. [2013]
Bupropion for smoking cessation in patients hospitalized with acute myocardial
infarction: a randomized, placebo-controlled trial. [2013]
The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence. [2013]
Sustained-release bupropion for smoking cessation in a Chinese sample: a
double-blind, placebo-controlled, randomized trial. [2013]
The DRD4 Exon III VNTR, Bupropion, and Associations With Prospective Abstinence. [2012]
A retrospective analysis of two randomized trials of bupropion for
methamphetamine dependence: suggested guidelines for treatment
discontinuation/augmentation. [2012]
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in
placebo-controlled clinical trials. [2012]
Effects of varenicline and bupropion on cognitive processes among
nicotine-deprived smokers. [2012]
Bupropion sustained release added to group support for smoking cessation in
schizophrenia: a new randomized trial and a meta-analysis. [2012]
Bupropion in the treatment of problematic online game play in patients with major
depressive disorder. [2012]
Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation. [2011.12]
Pilot Randomized Clinical Trial of an SSRI vs Bupropion: Effects on Suicidal Behavior, Ideation, and Mood in Major Depression. [2011.10.12]
Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled FMRI study on healthy males under subchronic paroxetine and bupropion. [2011.08]
Varenicline versus Bupropion XL for Smoking Cessation in Older Adolescents: A Randomized, Double-Blind Pilot Trial. [2011.07.20]
Bupropion and restless legs syndrome: a randomized controlled trial. [2011.07]
Bupropion for smoking cessation in patients with acute coronary syndrome. [2011.06.27]
Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation. [2011.06.09]
Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. [2011.05]
Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis. [2011.04.05]
Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. [2011.03.01]
Smoking cessation in primary care - a randomized controlled trial of bupropione, nicotine replacements, CBT and a minimal intervention. [2011.03]
Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. [2011.03]
Bupropion SR and contingency management for adolescent smoking cessation. [2011.01]
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. [2011.01]
Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in
menstruating women: a double-blind, placebo-controlled and randomized study. [2011]
The cost-effectiveness of aripiprazole as adjunctive therapy in major depressive disorder: Thai economic model. [2010.11]
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. [2010.11]
A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. [2010.09]
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. [2010.08.21]
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2010.08]
Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. [2010.07.27]
Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects. [2010.07]
Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial. [2010.06.17]
A bupropion smoking cessation clinical trial for cancer patients. [2010.06]
Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking. [2010.04]
Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder. [2010.04]
Bupropion and cognitive behavioral therapy for weight-concerned women smokers. [2010.03.22]
The impact of chronic bupropion on plasma cotinine and on the subjective effects of ad lib smoking: a randomized controlled trial in unmotivated smokers. [2010.02]
Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia. [2010.01.30]
Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. [2010.01.15]
Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation. [2010.01]
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults
(COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3
trial. [2010]
Effects of bupropion on simulated demand for cigarettes and the subjective
effects of smoking. [2010]
A bupropion smoking cessation clinical trial for cancer patients. [2010]
The effects of the adjunctive bupropion on male sexual dysfunction induced by a
selective serotonin reuptake inhibitor: a double-blind placebo-controlled and
randomized study. [2010]
Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin
transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia. [2010]
Double-blind, placebo-controlled comparison of the antidepressant efficacy and
tolerability of bupropion XR and venlafaxine XR. [2010]
Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. [2009.12]
Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment. [2009.10]
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. [2009.09.30]
The impact of chronic bupropion on plasma cotinine and on the subjective effects of ad lib smoking: A randomized controlled trial in unmotivated smokers. [2009.09.14]
A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics. [2009.07]
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2009.07]
Sustained-release bupropion for hospital-based smoking cessation: a randomized trial. [2009.06]
A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. [2009.01]
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. [2008.12]
A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation. [2008.12]
Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis. [2008.11]
Psychological mediators of bupropion sustained-release treatment for smoking cessation. [2008.09]
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. [2008.08.01]
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. [2008.08]
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2008.07.17]
Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. [2008.07]
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. [2008.06.01]
A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension. [2008.06]
Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion. [2008.04.02]
A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. [2008.04]
Bupropion for the treatment of methamphetamine dependence. [2008.04]
Bupropion improves attention but does not affect impulsive behavior in healthy young adults. [2008.04]
Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. [2008.03]
Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. [2008.01]
A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder. [2008]
Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence. [2008]
Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials. [2007.12]
Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: A randomized controlled trial. [2007.12]
Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. [2007.11]
A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care. [2007.09.10]
Bupropion SR for the treatment of smokeless tobacco use. [2007.09.06]
Efficacy of bupropion alone and in combination with nicotine gum. [2007.09]
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. [2007.08]
A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. [2007.08]
Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. [2007.08]
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. [2007.08]
Bupropion and nicotine patch as smoking cessation aids in alcoholics. [2007.08]
Bupropion and cognitive-behavioral treatment for depression in smoking cessation. [2007.07]
A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. [2007.07]
Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. [2007.06.26]
Bupropion and cognitive-behavioral therapy for smoking cessation in women. [2007.06]
Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. [2007.05]
Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR. [2007.05]
Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. [2007.04]
A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. [2007.04]
Bupropion SR for the treatment of smokeless tobacco use. [2007.03.10]
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. [2007.02]
Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. [2007.01.01]
Bupropion in the treatment of outpatients with asthma and major depressive disorder. [2007]
Bupropion for smokers hospitalized with acute cardiovascular disease. [2006.12]
Looking for boomerang effects: a pre-post experimental study of the effects of exposure of youth to television advertising for nicotine replacement therapy and Zyban. [2006.12]
No evidence for a major role of polymorphisms during bupropion treatment. [2006.11]
|